J. Goldman & Co’s AngioDynamics ANGO Stock Holding History

J. Goldman & Co’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-304,522	Closed	-$2.39M	–	406
2023 Q4	$2.39M	Hold	304,522	–	–	0.1%	176
2023 Q3	$2.23M	Buy	+304,522	New	+$2.53M	0.08%	196

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

J. Goldman & Co's ANGO Position: Q1 2024 in Review

J. Goldman & Co sold out of AngioDynamics (ANGO) in Q1 2024, closing a stake of 304,522 shares — an estimated $2.39M sold.

J. Goldman & Co first reported a position in ANGO in Q3 2023 and held it in 2 quarters. The position peaked at $2.39M in Q4 2023. 135 funds tracked by Wall St. Rank hold ANGO as of Q1 2024.

J. Goldman & Co reported no remaining AngioDynamics position as of Q1 2024 after selling out during the quarter.
J. Goldman & Co sold 304,522 AngioDynamics shares in Q1 2024, an estimated $2.39M.
J. Goldman & Co first reported a position in AngioDynamics in Q3 2023 and held it in 2 quarters.
J. Goldman & Co's AngioDynamics position peaked at $2.39M in Q4 2023.
135 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2024.

Based on J. Goldman & Co's 13F filing for Q1 2024, filed 15 May 2024.